These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 31645727)

  • 1. Somatic mutations and clonal dynamics in healthy and cirrhotic human liver.
    Brunner SF; Roberts ND; Wylie LA; Moore L; Aitken SJ; Davies SE; Sanders MA; Ellis P; Alder C; Hooks Y; Abascal F; Stratton MR; Martincorena I; Hoare M; Campbell PJ
    Nature; 2019 Oct; 574(7779):538-542. PubMed ID: 31645727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.
    Kim SK; Takeda H; Takai A; Matsumoto T; Kakiuchi N; Yokoyama A; Yoshida K; Kaido T; Uemoto S; Minamiguchi S; Haga H; Shiraishi Y; Miyano S; Seno H; Ogawa S; Marusawa H
    J Gastroenterol; 2019 Jul; 54(7):628-640. PubMed ID: 30756187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
    Pereira Tde A; Witek RP; Syn WK; Choi SS; Bradrick S; Karaca GF; Agboola KM; Jung Y; Omenetti A; Moylan CA; Yang L; Fernandez-Zapico ME; Jhaveri R; Shah VH; Pereira FE; Diehl AM
    Lab Invest; 2010 Dec; 90(12):1690-703. PubMed ID: 20697376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
    Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
    Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.
    Tobari M; Hashimoto E; Taniai M; Kodama K; Kogiso T; Tokushige K; Yamamoto M; Takayoshi N; Satoshi K; Tatsuo A
    J Gastroenterol Hepatol; 2020 May; 35(5):862-869. PubMed ID: 31597206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
    Terada T; Terasaki S; Nakanuma Y
    Cancer; 1993 Sep; 72(5):1551-6. PubMed ID: 8394196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
    Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
    Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
    Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
    J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis.
    Nakanuma Y; Ohta G
    Cancer; 1985 May; 55(10):2400-4. PubMed ID: 2985233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
    Pinyol R; Torrecilla S; Wang H; Montironi C; Piqué-Gili M; Torres-Martin M; Wei-Qiang L; Willoughby CE; Ramadori P; Andreu-Oller C; Taik P; Lee YA; Moeini A; Peix J; Faure-Dupuy S; Riedl T; Schuehle S; Oliveira CP; Alves VA; Boffetta P; Lachenmayer A; Roessler S; Minguez B; Schirmacher P; Dufour JF; Thung SN; Reeves HL; Carrilho FJ; Chang C; Uzilov AV; Heikenwalder M; Sanyal A; Friedman SL; Sia D; Llovet JM
    J Hepatol; 2021 Oct; 75(4):865-878. PubMed ID: 33992698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.
    Lin YH; Zhang S; Zhu M; Lu T; Chen K; Wen Z; Wang S; Xiao G; Luo D; Jia Y; Li L; MacConmara M; Hoshida Y; Singal AG; Yopp A; Wang T; Zhu H
    Gastroenterology; 2020 May; 158(6):1698-1712.e14. PubMed ID: 31972235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocarcinogenesis in non-cirrhotic liver is associated with a reduced number of clonal hepatocellular patches in non-tumorous liver parenchyma.
    Adam AC; Faudou V; Paschen SA; Adam OM; Kahl P; Drebber U; Fischer HP; Büttner R
    J Pathol; 2012 Nov; 228(3):333-40. PubMed ID: 22685011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study.
    Prabhakar T; Kaushal K; Prasad M; Gupta E; Sood A; Jain AK; Shukla A; Goel A; Duseja A; Saraya A; Shah S; Kumar G; Sarin SK
    Hepatol Int; 2023 Jun; 17(3):745-752. PubMed ID: 36940070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of chromosomal aberrations in large hepatocellular carcinomas by comparative genomic hybridization.
    Kitay-Cohen Y; Amiel A; Ashur Y; Fejgin MD; Herishanu Y; Afanasyev F; Bomstein Y; Lishner M
    Cancer Genet Cytogenet; 2001 Nov; 131(1):60-4. PubMed ID: 11734320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
    Dongiovanni P; Romeo S; Valenti L
    World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
    Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
    Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice.
    Chen WT; Ha D; Kanel G; Lee AS
    Neoplasia; 2014 Aug; 16(8):617-26. PubMed ID: 25220589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.